跳至主要内容
临床试验/ITMCTR2100005034
ITMCTR2100005034尚未招募4 期

Hospital centralized monitoring of clinical safety of Shenkang Injection after marketing

The First Affiliated Hospital of He'nan University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

性别
All

入选标准

  • During the monitoring period, inpatients receiving Shenkang injection treatment in each monitoring hospital.

排除标准

  • Inpatients who are unable to collect the information needed for this study.

研究者

发起方
The First Affiliated Hospital of He'nan University of Chinese Medicine

相似试验